Belimumab After Rituximab in Resistant Primary Juvenile SS

NCT06410833 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Sjogren's Syndrome
Pediatric ALL

Interventions

DRUG: Rituximab
DRUG: Belimumab

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]